Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gemacta 200mg Injection

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Gemcitabine (200mg)

Overview Gemacta 200mg Injection

Gemcitabine 200mg Injection treats several cancers, including non-small cell lung, breast, pancreatic, bladder, and ovarian. Administration is solely by a healthcare professional via injection. Dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect use or overdose can lead to severe complications. Therapeutic effects might not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include nausea, vomiting, appetite loss, alopecia, and thrombocytopenia. The medication can decrease blood cell counts (red and white), raising infection risk. Regular blood tests are essential to monitor blood cell counts, along with heart, liver, and uric acid levels. Inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent use of infection-fighting medications before starting treatment. Interaction with other drugs is possible; disclose all medications to your physician. This injection is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout treatment.

Primary Ingredients of Gemacta 200mg Injection

No text provided. Please provide the text you wish me to rephrase.

Uses of Gemacta 200mg Injection

Lung adenocarcinoma, breast carcinoma, pancreatic adenocarcinoma, bladder cancer, and ovarian carcinoma.

Major Benefits of Gemacta 200mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Gemacta 200mg Injection:

  • Nausea
  • Vomiting
  • Loss of appetite
  • Hair loss
  • Low blood platelets
  • Allergic reaction
  • Breathlessness
  • Decreased white blood cell count
  • Increased liver enzymes
  • Anemia (low number of red blood cells)
  • Flu-like symptoms
  • Blood in urine
  • Skin rash
  • Protein in urine

How to use Gemacta 200mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Gemacta 200mg Injection works:

Gemacta 200mg Injection halts cancer cell proliferation by disrupting DNA and RNA synthesis through the replacement of essential cellular components, thereby inhibiting tumor growth and expansion.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Gemacta 200mg Injection and alcohol can lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Gemacta 200mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Nevertheless, a physician might exceptionally prescribe it in life-threatening emergencies where the potential advantages outweigh the inherent dangers. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Administration of Gemacta 200mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates the drug may harm the nursing infant.

DrivingDrivingUNSAFE

Administering Gemacta 200mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving is strongly discouraged if these effects are experienced.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding Gemacta 200mg Injection's use in individuals with renal impairment. Physician consultation is necessary. Pre-treatment kidney function assessment is recommended, along with ongoing monitoring following administration.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Gemacta 200mg Injection to individuals with hepatic impairment. Seek medical advice from your physician.

What if you forget to take Gemacta 200mg Injection :

NA

Facts to Know About Gemacta 200mg Injection

LabelValue
Chemical Type Cytosine Analog
Developing Habits No.
Treatment Category Cancer Medications
Behavior Class Metabolic Inhibitors
Gemacta 200mg Injection
746
MRP 865
13% off